<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00202956</url>
  </required_header>
  <id_info>
    <org_study_id>JL-HM-01-01</org_study_id>
    <nct_id>NCT00202956</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy Study of Bugusan (BGS)to Treat Osteoporosis.</brief_title>
  <official_title>A Randomized, Double Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Effects on Biomarkers and Safety of Bugusan (BGS) in Postmenopausal Patients With Osteoporosis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Taichung Veterans General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Taichung Veterans General Hospital</source>
  <brief_summary>
    <textblock>
      The objective is to evaluate the effects on biomarkers and safety of BGS in postmenopausal
      patients with osteoporosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective is to evaluate the effects on biomarkers and safety of BGS in postmenopausal
      patients with osteoporosis by a study of Randomized, Double Blind, Placebo-Controlled,
      Parallel Group.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2004</start_date>
  <completion_date>May 2005</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <condition>Osteoporosis</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bugusan</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Postmenopausal women between the ages of 45 and 75 years with a natural menopause ≧ 6
             months and serum E2 values &lt; 20 pg/ml, serum FSH values ≧ 25 mIU/mL;

          2. Patients have bone mineral density ＜-2.5 SD of T score at the lumbar spine (L2-L4);

          3. All patients must sign the informed consent form (ICF) prior to the trial.

        Exclusion Criteria:

          1. Any X-ray film that documents substantial scoliosis, or spinal secondary osteoporosis;

          2. Any X-ray film that documents bone fracture within 3 month prior to the trial.

          3. Medication such as estrogen, bisphosphonates, calcitonin, fluoride, glucocorticoids,
             ipriflavone intake within 3 weeks prior to the trial;

          4. Use of other Chinese medicine within 2 weeks prior to the trial;

          5. Patients with significant renal function impairment (Creatinine&gt;2mg/dl) and liver
             function impairment (AST and ALT &gt; 2 x the upper limit of normal range);

          6. Patients have laboratory test abnormality, which in the investigator’s opinion might
             confound the study;

          7. Patients have severe cardiac disease, e.g. unstable angina pectoris, myocardial
             infarction, congestive heart failure (New York Heart Association Functional
             Classification III and IV);

          8. Patients have life threatening disease;

          9. Patients are allergic to any of the composition of Chinese medicine;

         10. Significant concomitant disease or medical history that could interfere with the study
             as judged by the investigator;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Huey-Herng Sheu</last_name>
    <role>Principal Investigator</role>
    <affiliation>Taichung Veterans General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Huey-Herng Sheu</last_name>
    <phone>8860402359-2525</phone>
    <phone_ext>4004</phone_ext>
    <email>whhsheu@vghtc.gov.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>Taichung Veterans General Hospital</name>
      <address>
        <city>Taichung</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Huey-Herng Sheu, Doctor</last_name>
      <phone>886-4-2359-2525</phone>
      <phone_ext>4004</phone_ext>
      <email>whhsheu@vghtc.gov.tw</email>
    </contact>
    <investigator>
      <last_name>Huey-Herng Sheu, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>September 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2005</study_first_submitted>
  <study_first_submitted_qc>September 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2005</study_first_posted>
  <last_update_submitted>September 12, 2005</last_update_submitted>
  <last_update_submitted_qc>September 12, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 20, 2005</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoporosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

